Atlas Trials

HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA)for Lung Cancer

Clinical trial NCT02523404 · COMPLETED

Trial details

NCT number
NCT02523404
Sponsor
Fuda Cancer Hospital, Guangzhou
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2015-05-01
Primary completion
2016-08-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.